WELL Health Technologies Corp.
WELL.TO
TSX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 6.47% | -4.05% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.47% | -4.05% | |||
| Cost of Revenue | 6.00% | -1.11% | |||
| Gross Profit | 7.07% | -7.51% | |||
| SG&A Expenses | 8.41% | -11.17% | |||
| Depreciation & Amortization | 5.96% | 14.95% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.81% | -3.81% | |||
| Operating Income | 0.47% | -8.21% | |||
| Income Before Tax | 101.33% | -136.57% | |||
| Income Tax Expenses | 630.07% | 89.12% | |||
| Earnings from Continuing Operations | -43.19% | -116.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 56.68% | 22.37% | |||
| Net Income | 13.72% | -154.23% | |||
| EBIT | 0.47% | -8.21% | |||
| EBITDA | 3.57% | 95.72% | |||
| EPS Basic | 13.75% | -154.36% | |||
| Normalized Basic EPS | 27.00% | -36.05% | |||
| EPS Diluted | 16.39% | -156.69% | |||
| Normalized Diluted EPS | 27.00% | -36.05% | |||
| Average Basic Shares Outstanding | 0.22% | -0.37% | |||
| Average Diluted Shares Outstanding | 0.22% | -0.37% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||